Approval · Notice of Compliance 20929 · 2018
RESTASIS MULTIDOSE: Notice of Compliance 20929
Issued June 1, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20929
- Date
- June 1, 2018
- Company
- Allergan IncMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RESTASIS MULTIDOSE | 02476835 | Marketed |
Medicinal ingredients
- CYCLOSPORINE 0.05 PER